Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19
H Fouladseresht, M Doroudchi, N Rokhtabnak… - Cytokine & growth factor …, 2021 - Elsevier
Abstract The coronavirus disease-2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), appears with a wide spectrum of mild-to-critical
clinical complications. Many clinical and experimental findings suggest the role of
inflammatory mechanisms in the immunopathology of COVID-19. Hence, cellular and
molecular mediators of the immune system can be potential targets for predicting,
monitoring, and treating the progressive complications of COVID-19. In this review, we …
syndrome coronavirus-2 (SARS-CoV-2), appears with a wide spectrum of mild-to-critical
clinical complications. Many clinical and experimental findings suggest the role of
inflammatory mechanisms in the immunopathology of COVID-19. Hence, cellular and
molecular mediators of the immune system can be potential targets for predicting,
monitoring, and treating the progressive complications of COVID-19. In this review, we …
以上显示的是最相近的搜索结果。 查看全部搜索结果